# AL-15469A for the Treatment of Bacterial Conjunctivitis

> **NCT00331916** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 600 (estimated)

## Conditions studied

- Bacterial Conjunctivitis

## Interventions

- **DRUG:** quinolone

## Key facts

- **NCT ID:** NCT00331916
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-05
- **Final completion:** —
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2009-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331916, "AL-15469A for the Treatment of Bacterial Conjunctivitis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00331916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*